CoreCap Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
LMFP
CIM
CGH
CNB
AP
COPPSERS
CoreCap Advisors's GILD Position: Q2 2026 in Review
CoreCap Advisors increased its Gilead Sciences (GILD) stake by 12% in Q2 2026, buying an estimated $664K and bringing the position to 46,624 shares worth $5.89M. The position accounts for 0.17% of the portfolio, ranked #132.
CoreCap Advisors first reported a position in GILD in Q4 2021 and has held it in 14 quarters since. 407 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- CoreCap Advisors held 46,624 shares of Gilead Sciences worth $5.89M as of Q2 2026.
- CoreCap Advisors bought 5,039 Gilead Sciences shares in Q2 2026, an estimated $664K.
- Gilead Sciences made up 0.17% of CoreCap Advisors's portfolio in Q2 2026, its #132 holding.
- CoreCap Advisors first reported a position in Gilead Sciences in Q4 2021 and has held it in 14 quarters since.
- 407 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.